Trade Summary

3 days ago, Yu Yong, serving as Chief Scientific Officer at GENELUX Corp (GNLX), sold 9,683 shares at $2.75 per share, for a total transaction value of $26,658.27. Following this transaction, Yu Yong now holds 258,688 shares of GNLX.

This sale represents a 3.61% decrease in Yu Yong's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, September 2, 2026 at 7:05 PM ET, 2 days after the trade was made.

GENELUX Corp operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.